AstraZeneca plc (ADR) (NYSE:AZN) ‘s stock had its “hold” rating reiterated by Jefferies Group in a research note issued on Wednesday, StockRatingsNetwork reports. AstraZeneca plc (ADR) (NYSE:AZN) stock opened at $68.49 in last trading session, and closed at $67.79, trading in the range of $67.68 – $68.53. The stock showed a negative weekly performance of -0.38%.
An experimental once-weekly medicine for type 2 diabetes developed by Eli Lilly and Co (NYSE:LLY) proved as effective in lowering blood sugar as Victoza from Danish drugmaker Novo Nordisk in an eagerly anticipated late stage study. Eli Lilly and Co (NYSE:LLY) shares closed at $58.48 on last trade day, by gaining 0.78%. Stock 52 week range is $47.53 – $58.90. Company’s market capitalization is $66.60 billion.
GlaxoSmithKline plc (NYSE:GSK) was downgraded by Zacks from a “neutral” rating to an “underperform” rating in a research note issued on Friday, ARN reports. They currently have a $51.00 target price on the stock. Zacks‘ target price indicates a potential downside of 8.52% from the company’s current price. GlaxoSmithKline plc (ADR) (NYSE:GSK) stock decreased -0.09% and finished the last session at $55.70. The EPS of the stock remained 3.70. Company’s market capitalization is $135.27 billion.
Star Scientific, Inc. (NASDAQ:STSI) stock has an average recommendation of Buy. Star Scientific, Inc. (NASDAQ:STSI) stock opened at $1.01 in last trading session and closed at $0.930. The 52 week range of the stock is $0.55 – $2.59 and the day range was $0.92 – $1.03.
Leave a Reply